Thomas R. Chauncey

Thomas R. Chauncey is an Academic Associate Professor in the Division of Hematology and Oncology at the University of Washington School of Medicine and serves as Director of the Marrow Transplant Unit at VA Puget Sound Health Care System in Seattle. His clinical practice is centered at the VA Puget Sound facility located at 1660 S. Columbian Way, Seattle, WA 98108.

Dr. Chauncey earned his M.D. from Rush Medical College and his Ph.D. from the University of Chicago. He completed his residency training at the University of Washington (UW) followed by a fellowship in Hematology-Oncology at the same institution. He is board certified in Internal Medicine and Medical Oncology by the American Board of Internal Medicine.

His primary research and clinical expertise focuses on hematopoietic stem cell transplantation and leukemia treatment. Dr. Chauncey's work has significantly contributed to the understanding of bone marrow transplantation techniques, graft-versus-host disease management, and treatment protocols for various hematologic malignancies. His research spans several decades, with publications ranging from basic biochemical studies in the 1980s to contemporary clinical transplantation research.

An analysis of his publication history reveals a consistent focus on improving outcomes in hematopoietic cell transplantation. His more recent work (2003-2013) has centered on optimizing conditioning regimens, understanding graft-versus-tumor effects, and exploring the role of natural killer cells in transplantation immunology. His earlier work included foundational studies in biochemistry and chemotherapy mechanisms.

Dr. Chauncey maintains strong institutional affiliations with the University of Washington (uwmedicine.org) and the Fred Hutchinson Cancer Center, positioning him at the forefront of hematologic malignancy research and treatment in the Pacific Northwest.

As Director of the Marrow Transplant Unit at VA Puget Sound, he leads a clinical team providing specialized care for veterans requiring stem cell transplantation. His dual academic and clinical roles enable him to translate research findings directly into patient care while mentoring the next generation of hematologists and oncologists.